Soleno Therapeutics Announces Proposed Public Offering of Common Stock
May 02, 2024 16:01 ET
|
Soleno Therapeutics
REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Nasdaq:SLNO), ("Soleno" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics...
Mustang Bio Announces Closing of $4 Million Public Offering
May 02, 2024 16:01 ET
|
Mustang Bio, Inc.
WORCESTER, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical...
WW International, Inc. Announces First Quarter 2024 Results
May 02, 2024 16:01 ET
|
WW International Inc.
End of Period Subscribers of 4.0 million, including 91 thousand End of Period Clinical SubscribersRevenues of $206.5 millionGross margin of 66.7%; excluding the net impact of restructuring charges...
Ascendis Pharma Reports First Quarter 2024 Financial Results
May 02, 2024 16:01 ET
|
Ascendis Pharma
— Rollout of YORVIPATH® initiated in Germany and Austria, with an estimated 55 doctors writing prescriptions and ~100 patients receiving commercial product as of March 31 — TransCon™ PTH...
Silvercrest Asset Management Group Inc. Reports Q1 2024 Results
May 02, 2024 16:01 ET
|
Silvercrest Asset Management Group Inc.
NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group Inc. (NASDAQ: SAMG) (the “Company” or “Silvercrest”) today reported the results of its operations for the quarter ended...
Willscot Mobile Mini Reports First Quarter 2024 Results
May 02, 2024 16:01 ET
|
WillScot Mobile Mini Holdings Corp.
PHOENIX, May 02, 2024 (GLOBE NEWSWIRE) -- WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC), a leader in innovative temporary flexible space solutions,...
Alignment Healthcare Reports First Quarter 2024 Results
May 02, 2024 16:01 ET
|
Alignment Healthcare USA, LLC
Reports $628.6 million in total revenue and $627.6 million in revenue excluding ACO REACH, up 43.1% and 54.2% year-over-year respectivelyMedicare Advantage membership grows 50.5% year-over-year to...
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Corporate Update
May 02, 2024 16:01 ET
|
Xenon Pharmaceuticals Inc.
VANCOUVER, British Columbia, May 02, 2024 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, today announced it will report its first...
Asure Announces First Quarter 2024 Results
May 02, 2024 16:01 ET
|
Asure Operations
Reports First Quarter Revenues of $31.7 Million Management Reiterates 2024 Revenue Guidance of $125.0 Million - $129.0 Million AUSTIN, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Asure Software, Inc....
Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of Directors
May 02, 2024 16:01 ET
|
Vor Biopharma
CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced the appointment of Fouad Namouni, M.D., to its Board...